Skip to main content
. 2015 Apr;56(2):78–84. doi: 10.3325/cmj.2015.56.78

Figure 5.

Figure 5

The effect of 50 µM SB202190 (p38 MAPK inhibitor), 50 µM SP600125 (JNK inhibitor), 50 µM PD184352 (ERK inhibitor), 10 µM wortmannin (PI3 kinase inhibitor), and 5 µM EX-527 (SIRT-1 inhibitor) on 3-h serum deprivation-induced caspase 3 activation and the protective action of 200 µM resveratrol. Only p38 MAPK inhibitor SB202190 abolished the effect of resveratrol on caspase activation.